Business
NuGen Medical Devices Inc. Announces CFO Transition
Toronto, Ontario--(Newsfile Corp. - January 30, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company"), a leader in needle-free subcutaneous drug-delivery technology, announces that Veronique Laberge has resigned from her position as Chief Financial Officer and Corporate Secretary. Her resignation is effective January 31, 2026.The Company has appointed Mr. Ajay Mishra as Chief Financial Officer and Corporate Secretary, effective January 31, 2026. Mr. Mishra will assume...
About this update from Nugen Medical Devices Inc
[{"type":"text","content":"Toronto, Ontario--(Newsfile Corp. - January 30, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company"), a leader in needle-free subcutaneous drug-delivery technology, announces that Veronique Laberge has resigned from her position as Chief Financial Officer and Corporate Secretary. Her resignation is effective January 31, 2026.","length":369,"tagName":"p"},{"type":"text","content":"The Company has appointed Mr. Ajay Mishra as Chief Financial Officer and Corporate Secretary, effective January 31, 2026. Mr. Mishra will assume responsibility for the Company's financial reporting and related functions.","length":224,"tagName":"p"},{"type":"text","content":"NuGen thanks Ms. Laberge for her contributions during her tenure with the Company.","length":82,"tagName":"p"},{"type":"text","content":"About NuGen Medical Devices","length":27,"tagName":"p"},{"type":"text","content":"NuGen develops next-generation needle-free devices for subcutaneous drug delivery. Its flagship InsuJet™ system is approved in 42 countries and is designed to improve the lives of millions of people with diabetes worldwide.","length":223,"tagName":"p"},{"type":"text","content":"Websites: insujet.com | insujet.fr | nugenmd.com","length":48,"tagName":"p"},{"type":"text","content":"LinkedIn: https://www.linkedin.com/company/nugen-medical-devices","length":64,"tagName":"p"},{"type":"text","content":"Investor Relations: [email protected]","length":34,"tagName":"p"},{"type":"text","content":"For further information, please contact:Liang Lin, Chief Executive Officer+ [email protected]","length":107,"tagName":"p"},{"type":"text","content":"Notice Regarding Forward-Looking Information:","length":45,"tagName":"p"},{"type":"text","content":"Neither TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accept responsibility for the adequacy or accuracy of this release.","length":171,"tagName":"p"},{"type":"text","content":"This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and ...